Cargando…
Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer
Silencing of O(6)-methylguanine-DNA-methyltransferase (MGMT) in tumors, mainly through promoter methylation, correlates with a better therapeutic response and with increased survival. Therefore, it is conceivable to consider MGMT as a potential therapeutic target for the treatment of cancers. Our pr...
Autores principales: | Canello, Tamar, Ovadia, Haim, Refael, Miri, Zrihan, Daniel, Siegal, Tali, Lavon, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252043/ https://www.ncbi.nlm.nih.gov/pubmed/25460932 http://dx.doi.org/10.1371/journal.pone.0113854 |
Ejemplares similares
-
Androgen receptor: a potential therapeutic target for glioblastoma
por: Zalcman, Nomi, et al.
Publicado: (2018) -
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
por: Denichenko, Polina, et al.
Publicado: (2019) -
STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes
por: Zveik, Omri, et al.
Publicado: (2022)